Nonetheless, the establishment of CNVs as risks for psychiatric disorders is an important breakthrough. The findings highlight commonalities across different neurodevelopmental disorders. The genes indexed by CNVs are beginning to provide valuable biological insights and clues to patterns of altered brain development and function that accompany disorders such as ASD, ADHD, and schizophrenia. CNV findings, by shedding light on pathogenesis, can contribute to progress in developing novel interventions and risk modification strategies that target relevant risk processes in the nearer future.
